Inventor · disambiguated record
Sudeep Prajapati
Also filed as: PRAJAPATI SUDEEP
12 granted patents·22 pending applications·25 citations·filing 2015–2025
87Inventor score
Top patents by PatentIndex Score
34 records- 0190US9434697B2Pyrimidine FGFR4 inhibitorsEISAI R&D MAN CO LTD·Filed 2016·Granted Sep 6, 2016·8 cites·30 claims
- 0289US9730931B2Pyrimidine FGFR4 inhibitorsEISAI R&D MAN CO LTD·Filed 2016·Granted Aug 15, 2017·7 cites·11 claims
- 0386US2025135017A1Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2024·Application pending·0 cites
- 0484US11352348B2Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2020·Granted Jun 7, 2022·1 cites·25 claims
- 0584US9481669B2Pladienolide pyridine compounds and methods of useEISAI R&D MAN CO LTD·Filed 2015·Granted Nov 1, 2016·7 cites·46 claims
- 0677US11945807B2Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2022·Granted Apr 2, 2024·0 cites·24 claims
- 0777US11679107B2Certain aryl pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2019·Granted Jun 20, 2023·1 cites·19 claims
- 0876US10912774B2Pyrimidine FGFR4 inhibitorsEISAI R&D MAN CO LTD·Filed 2019·Granted Feb 9, 2021·0 cites·20 claims
- 0974US2024368140A1Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2024·Application pending·0 cites
- 1072US11926619B2Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2019·Granted Mar 12, 2024·1 cites·18 claims
- 1170US12172986B2Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2019·Granted Dec 24, 2024·0 cites·46 claims
- 1267US2025333400A1Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2025·Application pending·0 cites
- 1367US2023301990A1Certain aryl pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2023·Application pending·0 cites
- 1460US11498916B2Crystalline FGFR4 inhibitor compound and uses thereofEISAI R&D MAN CO LTD·Filed 2019·Granted Nov 15, 2022·0 cites·18 claims
- 1560US2025109140A15-[5-(piperidin-4-yl)thieno[3,2-c]pyrazol-2-yl]indazole derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseasesREMIX THERAPUTICS INC·Filed 2023·Application pending·0 cites
- 1659US10537571B2Pyrimidine FGFR4 inhibitorsEISAI R&D MAN CO LTD·Filed 2017·Granted Jan 21, 2020·0 cites·12 claims
- 1759US2025082633A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1859US2025326748A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1959US2025092065A12-(indazol-5-yl)-6-(piperidin-4-yl)-1,7-naphthyridine derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseasesREMIX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2058US2023159496A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2158US2024366612A1Compounds and methods for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2258US2024279239A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2358US2025332173A1Compounds and methods for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2457US2024400584A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2557US2024409536A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2657US2024368163A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2757US2025333397A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2857US2025154169A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2957US2020361915A1Solid state form of pladienolide pyridine compounds and methods of useEISAI R&D MAN CO LTD·Filed 2020·Application pending·0 cites
- 3056US10745387B2Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(piridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate and methods of use thereofEISAI R&D MAN CO LTD·Filed 2016·Granted Aug 18, 2020·0 cites·26 claims
- 3152US2024239811A15-(5-(piperidin-4-yl)thieno[3,2-c]pyrazol-2-yl]indazole derivatives and related compounds as modulators for splicing nucleic acids and for the tREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3252US2024002375A12-(indazol-5-yl)-6-(piperidin-4-yl)-1,7-naphthyridine derivatives and related compounds as modulators for splicing nucleic acids and for the treREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3350US2018141913A1Tetrasubstituted alkene compounds and their useEISAI R&D MAN CO LTD·Filed 2017·Application pending·0 cites
- 3450US2020255415A1Tetrasubstituted alkene compounds and their use for the treatment of breast cancerEISAI R&D MAN CO LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sudeep Prajapati files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →